Key takeaways

• Agentic AI’s opportunity in life sciences goes beyond faster answers: it can help teams act on insights, adapt plans, respond to market signals and automate routine work.
• Life sciences expertise gives AI the context and critical grounding to interpret signals and shape recommendations that reflect real-world decisions, workflows and regulatory requirements.
• Lasting value depends on more than technology: clear guardrails, human oversight and changes in how teams work help organizations put agentic AI into practice and expand over time.

Life sciences organizations face declining provider access, pricing pressures and potential revenue decreases resulting from loss of exclusivity. As teams prepare for a promising pipeline of new launches, they must close the gap between recognizing these changes and responding to them.

Many organizations are responding with AI pilots, dashboards, CRM-centric agents and in-house experiments. Adding agents can improve individual workflows but agents alone do not guarantee the industry context needed for timely, appropriate action.

If agents are supposed to assist, augment or act on behalf of humans, they need full organizational context, deep understanding of the domain and deployment in the flow of work to be usable, valuable and trustworthy.

Why adding agents doesn’t resolve fragmented life sciences workflows

When life sciences organizations layer AI on top of fragmented data and disconnected workflows, the fragmentation remains. Relevant insights may not reach the teams permitted to use them in time to inform decisions.

Field signals may surface without prompting an updated plan or consistently informing content planning or patient activation. Commercial analytics may produce recommendations that are difficult to reconcile without the medical or patient context needed to determine an appropriate next step.

With life sciences domain context, however, agentic AI provides the opportunity to help teams act with a more complete understanding of their customers, patients and markets to accelerate commercialization and deepen engagement with patients and providers.

What self-driving cars reveal about life sciences intelligence

It took Waymo over 15 years to get to this level of understanding for self-driving—in a task that’s repetitive and predictable. This is a real-world example of what that requires: AI that interprets signals in context, anticipates what may happen and determines how to respond.

The world of life sciences business is more complex and dynamic, and it is not going to be autonomous anytime soon. Still, there are key lessons to be learned from Waymo for those of us building AI and agentic applications.

Its autonomous driving technology combines detailed maps with real-time sensor data to understand its surroundings, anticipate how other road users might move and plan its response. The company essentially built a world model, just like in life sciences what context and ontology provide, to tell the car exactly what the arena looks like.

Domain expertise turns data into life sciences intelligence

For life sciences, that progression begins with understanding the terminology, workflows, responsibilities and rules that give data meaning. That domain expertise spans terminology, taxonomy, specialized rules, regulatory expectations, patient journeys, commercial operations context, medical boundaries and content governance.

With that, agents can then monitor changing conditions, interpret their implications and recommend or carry out an appropriate next step within agreed guardrails. A change in healthcare provider access, for example, could inform an updated field plan rather than remain another finding in a report.

The goal is turning relevant intelligence into appropriate action, with human judgment where it is needed.

While generic AI can process language and summarize data, life sciences recommendations must reflect this expertise and fit the responsibilities and workflows of the team using them, within compliant guardrails.

How agentic applications coordinate life sciences workflows

Agentic applications also support individual functions and share relevant data and insights when work requires coordination. An update in one area can inform planning and actions elsewhere, reducing manual reconciliation and disconnected or conflicting activity.

This broader context helps teams identify changes sooner and align decisions while preserving functional boundaries and controls. Cross-functional coordination extends the value of individual applications; it’s not a prerequisite for every task.

How ZAIDYN supports planning, market responsiveness and workflow automation

ZAIDYN’s suite of connected applications for life sciences combines agentic AI with ZS’s more than forty years of life sciences domain expertise, including knowledge of the relationships, decisions and workflows that shape commercial, personalization, medical, patient and clinical work.

It brings that combination of domain, data and analytics expertise into everyday work in three related ways:

Accelerate planning and insight generation. By analyzing information and surfacing relevant insights, agents can help teams reassess priorities and adapt plans as conditions change.

Respond to market signals. Agents can help teams recognize emerging changes, understand their implications and recommend or initiate the appropriate next step within agreed controls.

Automate workflows. Agents can handle defined tasks, such as preparing content drafts and review materials, and coordinate multistep processes within agreed controls, reducing manual effort and freeing people to focus on work that requires judgment.

Together, these capabilities help teams move from understanding a change to responding to it.

ZAIDYN also is designed to provide visibility into logic flows, preserve the line between promotional and scientific work and support human oversight and controls appropriate to the task.

That visibility and control give teams a basis for reviewing recommendations, understanding how they fit their responsibilities and deciding where human judgment is required.

Implementing and scaling agentic AI in life sciences

ZAIDYN is designed to work with the CRM, data warehouse, human capital management and other systems companies already use, helping agentic AI operate in the flow of work. ZS supports strategy, implementation, change management and ongoing operation.

It’s modular, so organizations can begin with the functional applications that address their most immediate needs and expand over time.

Just as a self-driving car needs more than individual sensors, life sciences needs more than agents acting in isolation.

Agentic AI only creates value when organizations change how work gets done, how decisions are reviewed and how teams adopt new ways of working.

Explore ZAIDYN’s agentic AI for life sciences